In terms of regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed copy of newspaper advertisment published in English daily newspaper (Indian Express) and one daily newspaper (Financial Express) in Gujarati language of the region, where the registered office of the Company is situated for extract of Un-audited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended December 31st, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Earlier from Vivanza Biosciences
- Vivanza Biosciences Ltd. Press Release Feb 12 2026
- Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31ST December 2025
- Vivanza Biosciences Ltd. Press Release Feb 05 2026
- Board Meeting Intimation for Consideration Of Financial Result For The Quarter And Nine Months Ended 31St December, 2025
Later from Vivanza Biosciences
- Closure of Trading Window
- Vivanza Biosciences Ltd. Press Release Mar 23 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Vivanza Biosciences Ltd. Press Release Apr 07 2026
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences